Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Antiviral dihydropyrans from Biota

April 11, 1997

Retrospective analysis confirms efficacy and safety of Amphotec in aspergillosis

April 10, 1997

beta-Lactamase inhibitors described by SynPhar

April 10, 1997

Additional phase I/II trial results for MEDI-493

April 10, 1997

Antimicrobial/antineoplastic antibiotic discovered by Ajinomoto

April 9, 1997

Hybridon receives clearance to initiate further GEM-132 trials

April 8, 1997

Antibacterial mupirocin sulfamates from SmithKline Beecham

April 7, 1997

Novel antifungal discovered by Takara Shuzo

April 4, 1997

Cubist prepares inhibitors of isoleucyl-tRNA synthetase

April 4, 1997

Phase I/II results of MedImmune's MEDI-493 reported

April 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...